Product Information

FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5914 per EA under NDC 65862030801. Its NADAC has been published 514 times since Nov 28, 2013.

FDA first approved this application on Jul 9, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB

Fosinopril Sodium and Hydrochlorothiazide
$0.5914per EA

Strength

10; 12.5 mg/1; mg/1

NDC

65862030801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079245

FDA Approved

7/9/2009

TE Code

AB

On Market Since

7/9/2009

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 514 times since Nov 28, 2013, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5914 per EA
All-time high$1.0958 (Jun 12, 2019)
All-time low$0.3243 (May 17, 2023)
52-week high$0.6096
52-week low$0.3628
Median price$0.8619
Average price$0.7839
Largest weekly change+85.8% (Apr 17, 2024)
Weeks tracked514
Tracking sinceNov 28, 2013

Price History

1W

+5.9%

1M

+5.9%

3M

-3.0%

6M

+12.2%

1Y

+12.6%

3Y

+82.4%

5Y

-42.1%

All

-25.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.5914 per EA (NDC 65862030801), effective Aug 19, 2026.

How has the price of FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has declined 25.0%. It has been tracked across 514 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

Since Nov 28, 2013, the NADAC for FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.3243 (May 17, 2023) to a high of $1.0958 (Jun 12, 2019), with a median of $0.8619 per EA.

Are there cheaper alternatives to FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 65862030801) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.